Policy Archives | Page 6 of 16

NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

by Kevin McLaughlin

Cancer Care Moves Forward Amid COVID-19

Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.

by Kate Yandell

Using Leftover Cancer Drugs to Help Others

Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.

by Jon Kelvey

Forward Look

Makers of E-Cigarettes Tout Role in Smoking Cessation

Studies provide little evidence to support this claim.

by Stephen Ornes

Policy Matters

Taking Steps to Address Cancer Health Disparities

Cancer outcomes are changing for the better, but advances are not affecting all patients equally.

by Brian Rivers, PhD

The Coronavirus Impacts Cancer Clinical Trials

The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

by Anna Azvolinsky

Medicare Coverage for Next-Generation Sequencing Tests

Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

by Ashley P. Taylor

Opioid Overdoses in Cancer Patients and Survivors

The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.

by Emma Yasinski